310 Clinical Research — Inglewood, California

310 Clinical Research is a clinical research site located in Inglewood, California, United States 90301.

Crixeo Clinical Trials Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.

310 Clinical Research has participated in 16 clinical trials with 13 currently active.

Therapeutic areas: Metabolic Dysfunction Associated Steatohepatitis, Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a).

Sponsors: Boehringer Ingelheim, Eli Lilly and Company, Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 80/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 310 Clinical Research?

310 Clinical Research has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 310 Clinical Research conducted?

310 Clinical Research has 16 clinical trials on record, with 13 currently active. Their work covers Metabolic Dysfunction Associated Steatohepatitis, Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a).

Is 310 Clinical Research accredited by Crixeo Clinical Trials?

310 Clinical Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 310 Clinical Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.